التفاصيل البيبلوغرافية
| العنوان: |
BIN2 inhibition suppress ovarian cancer progression meanwhile protect ovarian function through downregulating HDAC1 and RPS6 phosphorylation respectively. |
| المؤلفون: |
Li, Cong‐Rong, Xie, Shi‐Ya, Zhang, Shu‐Ping, Yang, Yan‐Jie, Yang, Li‐Li, Cao, Ying, Wang, Li‐Li, Zhu, Feng‐Yu, Wang, Ruo‐Lei, Yang, Zhi‐Xia, Cui, Chen‐Chen, Li, Yan‐Ru, Xu, Jia‐Ning, Yue, Feng, Tian, Pei‐Zhe, Wang, Qian, Yao, Hong‐Jie, Guan, Yi‐Chun, Zhang, Shao‐Di, Ying, Xiao‐Yan |
| المصدر: |
Clinical & Translational Medicine; Oct2024, Vol. 14 Issue 10, p1-9, 9p |
| مصطلحات موضوعية: |
TUMOR suppressor genes, OVARIAN follicle, MEDICAL sciences, OVARIAN tumors, MERGERS & acquisitions |
| مستخلص: |
The article explores the potential of BIN2 inhibition in suppressing ovarian cancer progression and protecting ovarian function. Through various experiments, it was found that BIN2 inhibition or knockout can suppress tumor growth, improve fertility, and protect ovarian health by targeting HDAC1 and RPS6. The study suggests a novel therapeutic strategy for young ovarian cancer patients by understanding the dual function of BIN2 in cancer progression and ovarian function. [Extracted from the article] |
|
Copyright of Clinical & Translational Medicine is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| قاعدة البيانات: |
Complementary Index |
Full Text Finder